Baillie Gifford & Co
STAA icon

Baillie Gifford & Co’s STAAR Surgical STAA Stock Holding History

Baillie Gifford & Co’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,153,886
Closed -$28M – 281
2024
Q4 		$28M Sell
1,153,886
-306,599
-21% -$8.76M 0.02% 170
2024
Q3 		$54.3M Sell
1,460,485
-2,221,897
-60% -$82.9M 0.04% 139
2024
Q2 		$175M Sell
3,682,382
-432,518
-11% -$19M 0.14% 103
2024
Q1 		$158M Sell
4,114,900
-333,308
-7% -$10.8M 0.12% 104
2023
Q4 		$139M Sell
4,448,208
-469,918
-10% -$16.9M 0.11% 117
2023
Q3 		$198M Sell
4,918,126
-192,178
-4% -$9M 0.18% 93
2023
Q2 		$269M Sell
5,110,304
-14,037
-0.3% -$855K 0.23% 81
2023
Q1 		$328M Sell
5,124,341
-116,115
-2% -$7.58M 0.3% 74
2022
Q4 		$254M Buy
5,240,456
+112,653
+2% +$7.07M 0.27% 79
2022
Q3 		$362M Sell
5,127,803
-157,555
-3% -$13.5M 0.37% 68
2022
Q2 		$375M Buy
5,285,358
+38,684
+0.7% +$2.49M 0.38% 71
2022
Q1 		$419M Sell
5,246,674
-283,194
-5% -$21.1M 0.29% 75
2021
Q4 		$505M Buy
5,529,868
+65,849
+1% +$7.06M 0.28% 79
2021
Q3 		$702M Sell
5,464,019
-111,813
-2% -$15.6M 0.37% 71
2021
Q2 		$850M Buy
5,575,832
+1,404,968
+34% +$185M 0.41% 63
2021
Q1 		$440M Buy
4,170,864
+1,823,987
+78% +$183M 0.25% 92
2020
Q4 		$186M Buy
2,346,877
+25,405
+1% +$1.86M 0.1% 112
2020
Q3 		$131M Buy
2,321,472
+155,908
+7% +$8.4M 0.09% 111
2020
Q2 		$133M Buy
2,165,564
+197,048
+10% +$8.05M 0.1% 105
2020
Q1 		$63.5M Buy
1,968,516
+25,587
+1% +$862K 0.07% 106
2019
Q4 		$68.3M Buy
1,942,929
+34,641
+2% +$1.14M 0.07% 112
2019
Q3 		$49.2M Buy
1,908,288
+130,666
+7% +$3.97M 0.06% 122
2019
Q2 		$52.2M Buy
1,777,622
+3,421
+0.2% +$98.8K 0.06% 122
2019
Q1 		$60.7M Buy
1,774,201
+68,680
+4% +$2.43M 0.07% 116
2018
Q4 		$54.4M Buy
1,705,521
+155,342
+10% +$6.05M 0.07% 113
2018
Q3 		$74.4M Buy
1,550,179
+391,629
+34% +$16M 0.08% 105
2018
Q2 		$35.9M Buy
1,158,550
+86,575
+8% +$2.03M 0.04% 125
2018
Q1 		$15.9M Buy
1,071,975
+279,568
+35% +$4.37M 0.02% 152
2017
Q4 		$12.3M Buy
792,407
+93,665
+13% +$1.39M 0.02% 159
2017
Q3 		$8.7M Buy
698,742
+32,130
+5% +$358K 0.01% 167
2017
Q2 		$7.2M Buy
666,612
+177,072
+36% +$1.73M 0.01% 172
2017
Q1 		$4.8M Hold
489,540
– – 0.01% 174
2016
Q4 		$5.31M Buy
+489,540
New +$4.98M 0.01% 176

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Baillie Gifford & Co's STAA Position: Q1 2025 in Review

Baillie Gifford & Co sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 1,153,886 shares — an estimated $28M sold.

Baillie Gifford & Co first reported a position in STAA in Q4 2016 and held it in 33 quarters. The position peaked at $850M in Q2 2021. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Baillie Gifford & Co reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Baillie Gifford & Co sold 1,153,886 STAAR Surgical shares in Q1 2025, an estimated $28M.
  • Baillie Gifford & Co first reported a position in STAAR Surgical in Q4 2016 and held it in 33 quarters.
  • Baillie Gifford & Co's STAAR Surgical position peaked at $850M in Q2 2021.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Baillie Gifford & Co's 13F filing for Q1 2025, filed 7 May 2025.